
Inductive Bio accelerates small-molecule drug discovery by predicting and resolving ADMET challenges to prioritize viable compounds. It uses AI and machine learning models, generative chemistry, and chemist-in-the-loop workflows to run large-scale in-silico experiments and refine ideas into actionable recommendations. The platform offers products such as Beacon-1 for ADMET prediction and Compass for real-time design-stage predictions, delivered as SaaS plus expert services. Inductive Bio integrates diverse industry data via a pre-competitive consortium to improve model accuracy and serves biotech and pharmaceutical customers.

Inductive Bio accelerates small-molecule drug discovery by predicting and resolving ADMET challenges to prioritize viable compounds. It uses AI and machine learning models, generative chemistry, and chemist-in-the-loop workflows to run large-scale in-silico experiments and refine ideas into actionable recommendations. The platform offers products such as Beacon-1 for ADMET prediction and Compass for real-time design-stage predictions, delivered as SaaS plus expert services. Inductive Bio integrates diverse industry data via a pre-competitive consortium to improve model accuracy and serves biotech and pharmaceutical customers.